Background: Pentavalent antimonials are still the first choice treatment for leishmaniasis, but with low efficacy and resistance is emerging. In the present study, the effect of meglumine antimoniate (MA, Glucantime) combined with paromomycin, miltefosine or allopurinol on in vitro susceptibility of Leishmania tropica resistant isolate was evaluated.Method: The drugs were obtained from commercial sources and diluents of each drug in medium were prepared on the day of experiment. J774 A.1 murine macrophage cell lines were attached to the cultured on slide and incubated at 37 0C with 5% CO2 for 24 h. Then the stationary phase promastigotes were added to the cells and after 4 hrs of incubation different concentrations of MA, paromomycin, mil...
International audienceOBJECTIVES:Although miltefosine and paromomycin were only recently introduced ...
Objectives: To evaluate the in vitro activity of antileishmanial drugs, paromomycin and miltefosine,...
Introduction The treatment of leishmaniasis ischallenging, given the difficulties in drug administra...
Background: Pentavalent antimonials are still the first choice treatment for leishmaniasis, but wit...
Background: Pentavalent antimonials are still the first choice treatment for leishmaniasis, but with...
Cutaneous Leishmaniasis (CL) caused by Leishmania aethiopica is a public health and social problem w...
Cutaneous leishmaniasis (CL) due to L. braziliensis is associated with an exaggerated inflammatory r...
Cutaneous leishmaniasis is endemic in 88 different countries. There are an estimated 1.5 million new...
Background: Cutaneous Leishmaniasis (CL) is the most common form of leishmaniasis. CL can be divided...
Leishmaniasis is a poverty-related disease, the chemotherapy of which is based on few drugs. The in ...
Abstract INTRODUCTION: The treatment of mucosal leishmaniasis (ML) is difficult due to the toxicit...
The leishmanicidal activity of four batches of meglumine antimoniate, produced in Farmanguinhos-Fioc...
OBJECTIVES: To evaluate in vitro interactions between sitamaquine and the current antileishmanial dr...
AbstractLeishmaniasis is one of the most serious worldwide diseases caused by protozoan parasites of...
Leishmaniasis, a disease caused by parasites of the Leishmania genus, constitutes a significant heal...
International audienceOBJECTIVES:Although miltefosine and paromomycin were only recently introduced ...
Objectives: To evaluate the in vitro activity of antileishmanial drugs, paromomycin and miltefosine,...
Introduction The treatment of leishmaniasis ischallenging, given the difficulties in drug administra...
Background: Pentavalent antimonials are still the first choice treatment for leishmaniasis, but wit...
Background: Pentavalent antimonials are still the first choice treatment for leishmaniasis, but with...
Cutaneous Leishmaniasis (CL) caused by Leishmania aethiopica is a public health and social problem w...
Cutaneous leishmaniasis (CL) due to L. braziliensis is associated with an exaggerated inflammatory r...
Cutaneous leishmaniasis is endemic in 88 different countries. There are an estimated 1.5 million new...
Background: Cutaneous Leishmaniasis (CL) is the most common form of leishmaniasis. CL can be divided...
Leishmaniasis is a poverty-related disease, the chemotherapy of which is based on few drugs. The in ...
Abstract INTRODUCTION: The treatment of mucosal leishmaniasis (ML) is difficult due to the toxicit...
The leishmanicidal activity of four batches of meglumine antimoniate, produced in Farmanguinhos-Fioc...
OBJECTIVES: To evaluate in vitro interactions between sitamaquine and the current antileishmanial dr...
AbstractLeishmaniasis is one of the most serious worldwide diseases caused by protozoan parasites of...
Leishmaniasis, a disease caused by parasites of the Leishmania genus, constitutes a significant heal...
International audienceOBJECTIVES:Although miltefosine and paromomycin were only recently introduced ...
Objectives: To evaluate the in vitro activity of antileishmanial drugs, paromomycin and miltefosine,...
Introduction The treatment of leishmaniasis ischallenging, given the difficulties in drug administra...